Basics Eli Lilly & Co. Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products. IPO Date: January 2, 1990 Sector: Healthcare Industry: Pharma Market Cap: $904.25B Activated in VL: True Average Daily Range Avg Daily Range: $1.87 | 0.95% Avg Daily Range (30 D): $15.27 | 1.59% Avg Daily Range (90 D): $11.99 | 1.45% Institutional Daily Volume Avg Daily Volume: 4.35M Avg Daily Volume (30 D): 3.47M Avg Daily Volume (90 D): 3.79M Trade Size Avg Trade Size (Sh.): 117 Avg Trade Size (Sh.) (30 D): 22 Avg Trade Size (Sh.) (90 D): 25 Institutional Trades Total Inst.Trades: 86,935 Avg Inst. Trade: $9.57M Avg Inst. Trade (30 D): $89.49M Avg Inst. Trade (90 D): $77.72M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 15 Market Closing Trades Avg Closing Trade: $85.34M Avg Closing Trade (30 D): $456.66M Avg Closing Trade (90 D): $378.9M Avg Closing Volume: 414.63K     News Dec 6, 2025 @ 10:07 PM Eli Lilly's Stock Drops as It Slashes the Price of... Source: Prosper Junior Bakiny Dec 6, 2025 @ 2:10 PM Peptide Therapeutics Market Size to Reach USD 82.1... Source: Sns Insider Dec 5, 2025 @ 9:05 PM Do These 3 Healthcare Stocks Need a Checkup? Source: Reuben Gregg Brewer Dec 5, 2025 @ 4:05 PM This Pharmaceutical Giant Fell by 10% After a Setb... Source: Prosper Junior Bakiny Dec 3, 2025 @ 6:10 PM 1 Reason to Buy Eli Lilly Hand Over Fist Before th... Source: Adria Cimino Financials   TTM Q3 2025 Q2 2025 Basic EPS $20.49 $6.22 $6.3 Diluted EPS $20.44 $6.21 $6.29 Revenue $ 59.42B $ 17.6B $ 15.56B Gross Profit $ 49.34B $ 14.59B $ 13.11B Net Income / Loss $ 18.41B $ 5.58B $ 5.66B Operating Income / Loss $ 22.5B $ 7.23B $ 6.78B Cost of Revenue $ 10.08B $ 3.01B $ 2.45B Net Cash Flow $ 6.42B $ 6.42B $ 282.6M PE Ratio 49.63